Zhaopeng Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhaopeng Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Changwen Zhang
Department of Urology, Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University
2 shared publications - Jianxi Shi
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
2 shared publications - Zhihong Zhang
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
2 shared publications - Cao Fenghong
Department of Urology, North China University of Science and Technology Affiliated Hospital, China
1 shared publication - Duo Zhao
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
1 shared publication - Shaosan Kang
Department of Urology, North China University of Science and Technology Affiliated Hospital, Tangshan, China
1 shared publication
Latest Publications
- Open Access
- 4 May 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 297, 118268
The PPARβ/CERK/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferation
- 4 May 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 297, 118268
Open AccessThe PPARβ/CERK/C1P signaling pathway is a potential mechanism by which antimony exposure promotes prostate cancer cell proliferation
- Open Access
- 29 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4995
The Present and Future of Artificial Intelligence in Urological Cancer
Artificial intelligence has drawn more and more attention for both research and application in the field of medicine. It has considerable potential for urological cancer detection, therapy, and prognosis prediction due to its ability to choose features in data to complete a particular task autonomously. Although the clinical application of AI is still immature and faces drawbacks such as insufficient data and a lack of prospective clinical trials, AI will play an essential role in individualization and the whole management of cancers as research progresses. In this review, we summarize the applications and studies of AI in major urological cancers, including tumor diagnosis, treatment, and prognosis prediction. Moreover, we discuss the current challenges and future applications of AI.
- 29 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4995
Open AccessThe Present and Future of Artificial Intelligence in Urological Cancer
Artificial intelligence has drawn more and more attention for both research and application in the field of medicine. It has considerable potential for urological cancer detection, therapy, and prognosis prediction due to its ability to choose features in data to complete a particular task autonomously. Although the clinical application of AI is still immature and faces drawbacks such as insufficient data and a lack of prospective clinical trials, AI will play an essential role in individualization and the whole management of cancers as research progresses. In this review, we summarize the applications and studies of AI in major urological cancers, including tumor diagnosis, treatment, and prognosis prediction. Moreover, we discuss the current challenges and future applications of AI.